摘要脂质在动脉粥样硬化(以下简称 AS)形成中的作用一直是被研究得最多最深入的领域。尤其是近些年来对脂质受体和载脂蛋白的研究,使脂质在 AS 形成中的作用认识发展到了一个新的里程碑。但重视脂质的重要性,并不是说 AS 的发生仅是由于脂质被动浸润的结果。事实上 AS 发生是由多种原因,例如机械因素、感染因素、理化因素。
2Benn M, Watts GF, Tybjaerg-Hansen A, et al. Familial hyperchol- esterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowerlng medication [ J ] . Clin En- docrinol Metab, 2012, 97(11): 3 956 -964.
3Nordestgaard BG, Chapman M J, Humphries SE, et al. Familial hy- percholesterolaemia is underdiagnosed and undertreated in the gener- al population: guidance forclinicians to prevent coronary heart dis- ease: Consensus Statement of the European Atherosclerosis Society [J]. Eur Hear J, 2013, 34(45) : 3 478-490.
4Mabuchi H, Koizumi J, Shimizu M, et al. Development of coronary heart disease in familial hypercholesterolemia [ J]. Circulation, 1989, 79: 225-232.
5. Goldberg AC, Hopkins PN, Toth PP, et al. Familial hypercholes- terolemia : screening, diagnosis and management of pediatric and a- dult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia [ J ]. Clin Lipidol, 2011, 5(3) : S1-S8.
6Scientific Steering Committee on behalf of the Simon Breome Register Group. Mortality in treated heterozygous familial hypercholesterolae- mia: implications for clinical management [ J ]. Atheresclerosis, 1999, 142: 105-112.
7Mabuchi H. Introduction to Hyperlipidemia [ M ]. Edited by Asai H, Bunkodo, Tokyo, 2005; 35-61.
8Huijgen R, Hutten BA, Kindt I, et al. Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterol- emia: a cresssectional study in 26,406 individuals tested for genetic FH[J]. Cire Cardiovase Genet, 2012, 5 (3) : 354-359.
9Starr B, Hadfield SG, Hutten BA, et al. Development of sensitive and specific age- and gender-specific lowdensity lipoprotein choles- terol cutoffs for diagnosis of first-degree relatives with familial hy- percholesterolaemia in cascade testing [ J ]. Clin Chem Lab Med, 2008, 46 : 791-803.
10National Institute for Health and Clinical Excellence. Identification and management of familial hypercholesterolaemia. Clinical Guid- ance 71 2008. London: NICE 2008. http://guidance, nice. org. uk/CG71/Guidance/pdf/English ( Accessed May 2012).
